Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 428

Results For "CHI"

5487 News Found

Emmes launches Advantage eClinical as a standalone cloud-native clinical technology platform
Biotech | May 12, 2022

Emmes launches Advantage eClinical as a standalone cloud-native clinical technology platform

The cloud platform will empower biotech companies and CROs with an integrated solution for clinical data management and is supported by Emmes specialist data management teams


Dr. Agarwal's Health Care raises over Rs 1,000 crore from TPG Growth and Temasek
Hospitals | May 11, 2022

Dr. Agarwal's Health Care raises over Rs 1,000 crore from TPG Growth and Temasek

The company also raised Rs 270 crore investment from Temasek in 2019


Cipla posts consolidated PAT of Rs. 362.07 crore in Q4 FY2022
News | May 11, 2022

Cipla posts consolidated PAT of Rs. 362.07 crore in Q4 FY2022

Cipla has reported consolidated financial results for the period ended March 31, 2022


FirstCure Health raises US $350 K in the Pre-Seed funding round
Startup | May 11, 2022

FirstCure Health raises US $350 K in the Pre-Seed funding round

The funding will enable the company to expand into the segment of HealthCare Service offerings, both in terms of geography and operations


Alembic Pharmaceuticals receives USFDA  approval for Arformoterol Tartrate
Drug Approval | May 11, 2022

Alembic Pharmaceuticals receives USFDA approval for Arformoterol Tartrate

This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies


Dr. Reddy's to commercialise Tegoprazan in India and six emerging markets
News | May 11, 2022

Dr. Reddy's to commercialise Tegoprazan in India and six emerging markets

HK inno.N Corporation will be responsible for the manufacture and supply of Tegoprazan, while Dr. Reddy's will handle local clinical development, registration, marketing and sales


Hetero unveils new logo and corporate brand identity
News | May 11, 2022

Hetero unveils new logo and corporate brand identity

The new logo is a refreshing change from the version that has served Hetero well for three decades. And yet its reflection can be seen in the new version


DSM, UNICEF and Sight and Life extend global partnership to address malnutrition
Healthcare | May 11, 2022

DSM, UNICEF and Sight and Life extend global partnership to address malnutrition

The partners also aim to expand their work to Latin America for the first time


New nirsevimab data analyses reinforce efficacy against RSV
Biotech | May 11, 2022

New nirsevimab data analyses reinforce efficacy against RSV

Nirsevimab is the first investigational immunization designed to protect all infants across the RSV season with a single dose


Bayer posts higher sales, profit in first quarter
News | May 11, 2022

Bayer posts higher sales, profit in first quarter

Company's net income rose by 57.5 percent to 3.291 billion euros in Q1